“The Global Fetal & Neonatal Care Equipment market is estimated to be worth $8.3bn in 2023” says new Visiongain report
05 October 2018
Visiongain has launched a new pharma report: Global Fetal & Neonatal Care Equipment Market Forecast 2018-2028: Fetal, Neonatal, Ultrasound Devices, Fetal MRI Systems, Fetal Monitors, Fetal Pulse Oximeters, Warmer & Incubator, Phototherapy Equipment, Respiratory Devices, Neonatal Monitoring Devices, Hospitals, Clinics, Others
Fetal and neonatal care are emerging as a vital aspect in medical healthcare industry. The fetal and neonatal care comprises measures from early embryonic development through full foetus development and philosophical changes at the time of birth and one month post-delivery as a new born infant. Both fetal and neonatal growth and development are interconnected to the genetic and environmental factors. According to American Academy of Paediatrics, approximately 10% of the infants need birth assistance and ~ 1% need extensive care at the time of birth.
The lead analyst of the report commented "The fetal and neonatal care equipment market is anticipated to witness a strong growth during the forecast period. The key factor attributing to the growth of the market are increasing incidence and prevalence of pre-term birth, still birth, neonatal health complication, and other mother and neonatal pregnancy associated diseases.
The warmer & incubator held the largest share in Neonatal Care Equipment market and is expected to continue leading the market during the forecast period. However, with the increasing awareness for neonates vital analysis, the neonatal monitoring devices is anticipated to witness the second highest growth during the forecast period."
Leading companies featured in the report include Dragerwerk AG & Co. KGaA, Fisher & Paykel, GE Healthcare, Masimo Corporation, Medtronic plc, Natus Medical Inc., Philips Healthcare, Phoenix Medical Systems Pvt. Ltd.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100
About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Recent News
Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
21 September 2023
Read
Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033
The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.
14 September 2023
Read
Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033
The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.
13 September 2023
Read
Visiongain Publishes Immuno-Oncology Clinical Trials Market Report 2023-2033
Immuno-Oncology Clinical Trials market is valued at US$6,849.8 million in 2023 and is projected to grow at a CAGR of 11.3% during the forecast period 2023-2033.